Allianz Asset Management
TMO icon

Allianz Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Allianz Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.96M Buy
16,200
+1,800
+13% +$977K 0.01% 964
2025
Q4 		$8.34M Sell
14,400
-6,000
-29% -$3.39M 0.01% 923
2025
Q3 		$9.89M Buy
20,400
+10,100
+98% +$4.7M 0.01% 846
2025
Q2 		$4.18M Sell
10,300
-8,200
-44% -$3.43M 0.01% 1190
2025
Q1 		$9.21M Buy
18,500
+3,800
+26% +$2.06M 0.01% 830
2024
Q4 		$7.65M Buy
14,700
+12,900
+717% +$7.09M 0.01% 850
2024
Q3 		$1.11M Sell
1,800
-100
-5% -$59.2K ﹤0.01% 1610
2024
Q2 		$1.05M Buy
1,900
+1,400
+280% +$802K ﹤0.01% 1568
2024
Q1 		$291K Sell
500
-15,400
-97% -$8.64M ﹤0.01% 1762
2023
Q4 		$8.44M Sell
15,900
-14,400
-48% -$6.97M 0.01% 736
2023
Q3 		$15.3M Buy
30,300
+14,200
+88% +$7.57M 0.03% 569
2023
Q2 		$8.4M Sell
16,100
-3,700
-19% -$2M 0.02% 699
2023
Q1 		$11.4M Sell
19,800
-14,900
-43% -$8.4M 0.02% 645
2022
Q4 		$19.1M Buy
34,700
+7,000
+25% +$3.71M 0.04% 484
2022
Q3 		$14M Buy
27,700
+13,600
+96% +$7.61M 0.03% 557
2022
Q2 		$7.66M Sell
14,100
-3,100
-18% -$1.71M 0.01% 967
2022
Q1 		$10.2M Sell
17,200
-4,700
-21% -$2.7M 0.01% 987
2021
Q4 		$14.6M Sell
21,900
-10,900
-33% -$6.81M 0.01% 873
2021
Q3 		$18.7M Buy
32,800
+23,300
+245% +$12.8M 0.01% 768
2021
Q2 		$4.79M Buy
9,500
+400
+4% +$189K ﹤0.01% 1134
2021
Q1 		$4.15M Buy
+9,100
New +$4.34M ﹤0.01% 1143
2020
Q3 		– Sell
-31,700
Closed -$11.5M – 2378
2020
Q2 		$11.5M Sell
31,700
-7,300
-19% -$2.45M 0.01% 834
2020
Q1 		$11.1M Sell
39,000
-71,100
-65% -$22.4M 0.01% 804
2019
Q4 		$35.8M Buy
110,100
+12,100
+12% +$3.67M 0.03% 534
2019
Q3 		$28.5M Sell
98,000
-13,100
-12% -$3.75M 0.03% 637
2019
Q2 		$32.6M Buy
111,100
+20,700
+23% +$5.7M 0.03% 589
2019
Q1 		$24.7M Sell
90,400
-50,400
-36% -$12.5M 0.02% 678
2018
Q4 		$31.5M Sell
140,800
-25,900
-16% -$6.08M 0.03% 511
2018
Q3 		$40.7M Sell
166,700
-30,200
-15% -$6.95M 0.04% 518
2018
Q2 		$40.8M Buy
196,900
+10,600
+6% +$2.25M 0.04% 496
2018
Q1 		$38.5M Sell
186,300
-483,200
-72% -$101M 0.04% 546
2017
Q4 		$127M Buy
669,500
+45,100
+7% +$8.64M 0.1% 242
2017
Q3 		$118M Buy
624,400
+135,700
+28% +$24.6M 0.1% 236
2017
Q2 		$85.3M Buy
488,700
+61,800
+14% +$10.4M 0.08% 287
2017
Q1 		$65.6M Sell
426,900
-376,600
-47% -$57.6M 0.06% 376
2016
Q4 		$113M Buy
803,500
+316,400
+65% +$46.6M 0.1% 231
2016
Q3 		$77.5M Buy
487,100
+44,500
+10% +$6.86M 0.08% 280
2016
Q2 		$65.4M Buy
442,600
+256,600
+138% +$37.9M 0.07% 315
2016
Q1 		$26.3M Buy
186,000
+800
+0.4% +$107K 0.03% 649
2015
Q4 		$26.3M Buy
185,200
+67,400
+57% +$8.99M 0.03% 622
2015
Q3 		$14.4M Sell
117,800
-67,400
-36% -$8.78M 0.02% 838
2015
Q2 		$24M Buy
185,200
+44,400
+32% +$5.79M 0.03% 709
2015
Q1 		$18.9M Sell
140,800
-14,100
-9% -$1.82M 0.02% 717
2014
Q4 		$19.4M Buy
154,900
+91,500
+144% +$11.1M 0.02% 724
2014
Q3 		$7.72M Buy
+63,400
New +$7.71M 0.01% 927

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allianz Asset Management's TMO Position: Q1 2026 in Review

Allianz Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2026, selling an estimated $58.8M and leaving 418,106 shares worth $206M. The position accounts for 0.22% of the portfolio, ranked #91.

Allianz Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.01B in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Allianz Asset Management held 418,106 shares of Thermo Fisher Scientific worth $206M as of Q1 2026.
  • Allianz Asset Management sold 108,291 Thermo Fisher Scientific shares in Q1 2026, an estimated $58.8M.
  • Thermo Fisher Scientific made up 0.22% of Allianz Asset Management's portfolio in Q1 2026, its #91 holding.
  • Allianz Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's Thermo Fisher Scientific position peaked at $1.01B in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.